Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses (Q34365292)

1 August 2017

Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses (English)

1 reference

1 August 2017

1 reference

Maryam Ahmed

1

1 reference

1 August 2017

Scott D Cramer

series ordinal

2

1 reference

1 August 2017

Douglas S Lyles

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

1 August 2017

16

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

1 August 2017

330

1 reference

1 August 2017

34-49

1 reference

1 August 2017

1

1 reference

Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Getting oncolytic virus therapies off the ground

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Vesicular stomatitis virus: an exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

The growth inhibitory effect of p21 adenovirus on androgen-dependent and -independent human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus I. Analysis of neutralizing epitopes with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Cytopathogenesis and inhibition of host gene expression by RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Interferon induction by viruses. XXII. Vesicular stomatitis virus-Indiana: M-protein and leader RNA do not regulate interferon induction in chicken embryo cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Clonal growth characteristics of adult human prostatic epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Viral replication in olfactory receptor neurons and entry into the olfactory bulb and brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Progress in active specific immunotherapy of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

Bcl-xL Mediates a Survival Mechanism Independent of the Phosphoinositide 3-Kinase/Akt Pathway in Prostate Cancer Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.039

10.1016/J.VIROL.2004.08.039

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference